Table 1.
Final step in the hierarchical regression of predictors of post chemotherapy nausea.
| A) Average Nausea | b | SE | β | Sig. |
|---|---|---|---|---|
| Age*** | −.03 | .01 | −.27 | <001 |
| Gender | .13 | .28 | .02 | .65 |
| Motion Sickness | .02 | .10 | .01 | .84 |
| Lymphoma† | −.40 | .21 | −.10 | .06 |
| Other Diagnosis† | .42 | .60 | .03 | .48 |
| Study Group | .03 | .05 | .02 | .53 |
| Baseline QoL* | −.01 | .00 | −.09 | .024 |
| Expectancy*** | .27 | .06 | .17 | <001 |
| B) Peak Nausea | b | SE | β | Sig. |
| Age*** | −.05 | .01 | −.26 | <001 |
| Gender | −.10 | .49 | −.01 | .83 |
| Motion Sickness | .11 | .17 | .02 | .52 |
| Lymphoma†* | −.84 | .37 | −.12 | .023 |
| Other Diagnosis† | .20 | 1.03 | .01 | .85 |
| Study Group | .13 | .09 | .05 | .17 |
| Baseline QoL* | −.01 | .01 | −.08 | .048 |
| Expectancy*** | .43 | .11 | .15 | <001 |
†
Dummy coded with breast cancer as the reference group.
*
Significant at p<0.05,
***
Significant at p<0.001.